BCL10 Antikörper (AA 122-168)
Kurzübersicht für BCL10 Antikörper (AA 122-168) (ABIN2209252)
Target
Alle BCL10 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 122-168
-
Kreuzreaktivität
- Human
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
-
Produktmerkmale
- BCL10 (B Cell CLL/lymphoma 10, B Cell Leukemia/lymphoma 10, CARD-containing Molecule enhancing NF-kappa-B, CARD-like apoptotic Protein, caspase-recruiting domain-containing Protein, CED-3/ICH-1 Prodomain Homologous E10-like Regulator, Cellular Homolog of vCARMEN, Cellular-E10, cE10, CIPER, hCLAP, mE10, R-RCD1) (BSA & Azide Free)
-
Aufreinigung
- Purified by Protein A/G affinity chromatography.
-
Immunogen
- Human BCL10 recombinant protein (epitope aa122-168). Cellular Localization: Nuclear and cytoplasmic
-
Isotyp
- IgG1 kappa
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- BCL10 (B-Cell CLL/lymphoma 10 (BCL10))
-
Andere Bezeichnung
- BCL10
-
Hintergrund
- Cellular Localization: Nuclear and cytoplasmic
-
Pathways
- T-Zell Rezeptor Signalweg, Fc-epsilon Rezeptor Signalübertragung, Activation of Innate immune Response, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Tube Formation, Positive Regulation of Endopeptidase Activity, BCR Signaling, Ubiquitin Proteasome Pathway, S100 Proteine
Target
-